Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

The Trade Group Donates Customized Safety Signage, Face Shields and Sanitizer Stations to North Texas Food Bank


The Trade Group — an award-winning, creative and experiential design firm—is pleased to announce that it recently donated design, manufacturing and installation services of safety signage and equipment to the North Texas Food Bank (NTFB). The items were installed throughout the NTFB’s Perot Family Campus in Plano, including warehouse, production line, office, kitchen and conference room workspaces, as well as restrooms and elevators.

According to Robin Dean, Senior Design Consultant at The Trade Group, “We’re honored to be able to donate these safety solutions to the North Texas Food Bank, an organization that feeds thousands of North Texas families, children and seniors every day. We also hope that the signage, face shields and sanitizer stations The Trade Group has donated will bring peace of mind to the hundreds of employees and volunteers continuing to work hard to feed our communities during the pandemic.”

Dean, who toured the NTFB’s Plano location in June, enjoyed working with The Trade Group’s design and production teams to create a customized solution for the diverse and expansive facility. The deliverables included different types of safety, awareness and social distancing signage, including banners, banner stands, floor decals and window and mirror clings.

The Trade Group also donated a custom 15-foot clear, acrylic, protective reception shield to provide separation between the receptionist and guests. Other deliverables included hand sanitizer stations with custom graphics and PPE face shields for employees and volunteers to help mitigate virus spread.

According to Anna Kurian, Sr. Director of Marketing and Communications for NTFB, “We’re a critical organization, and an essential organization, so we have been allowed to stay open throughout this time. But in order to maintain that safety we need to make sure people follow safety protocols. We’re grateful to have received these items from the Trade Group because it helps us keep our employees, our staff and everyone who comes through the door safe.”

While The Trade Group may be known for its design and fabrication work for the trade show industry, the company has also been designing office and corporate interiors for years. The company tapped into this area of expertise as it has been helping more organizations, like the North Texas Food Bank, modify workspaces to enhance safety during COVID-19.

“The Trade Group helps clients transform their office and work spaces utilizing the same materials we use as a part of our custom design solutions for the event and trade show industry. In light of COVID-19, it was a natural path for us to add safety solutions to our list of offerings, too. We stock most of the materials we use onsite and also have complete printing and fabricating capabilities in house. Having these resources on hand makes it easy for us to turn projects around quickly and provide the turnkey solutions our clients really appreciate,” Dean says.

To learn more about The Trade Group’s corporate interior design solutions to modify workplaces in accordance with COVID-19 safety directives, please call 800-343-2005 or visit the COVID-19 resources page on The Trade Group’s website.

ABOUT THE TRADE GROUP:

The Trade Group is an award-winning, full-service event marketing and creative design firm, specializing in trade shows, esports events and activations, corporate events, brand activations, corporate interiors, retail merchandising, commercial graphics and experiential solutions. Since 1986, the company’s team of live event, design and engineering experts has helped thousands of clients amplify their brands and successfully navigate a wide range of events and experiences. Clients rely on The Trade Group for: event ideation, creation and production; esports expertise; exhibit design and fabrication; graphic design and production; strategic marketing solutions; technology integration and more.

Press Contact:

Becca Richardson

Marketing Manager

The Trade Group

brichardson@tradegroup.com

Share article on social media or email:

For the Third Straight Year Dr. Samuel A. Joseph, Jr. Named to Tampa Magazines’ Top Doctors List


Our patients come to us in pain and we use our expertise m diagnosis, education, and treatment to help move them forward to improved spine function and health. – Dr. Samuel Joseph, founder.

In May, Tampa Magazines sent surveys to more than 9,000 physicians practicing in Hillsborough, Pinellas. and Pasco counties asking them to nominate the peers they believe stand out from the rest. Tampa Bay physicians chose 273 of their peers from 67 practice areas as this year’s Top Doctors.

Dr. Samuel Joseph is dedicated to pioneering minimally invasive outpatient surgical techniques along with scoliosis and revision surgeries. He performed Tampa Bay area’s first Robotic Endoscopically Assisted Percutaneous Outpatient Spinal Fusion at Memorial Hospital of Tampa. Dr. Joseph believes in partnering with other leaders in the spine industry to bring advanced spine procedures to the Bay area.

Dr. Joseph has published numerous articles in neurosurgical and orthopaedic spine journals. His research on scoliosis, degenerative disc disease, and spinal surgery in the elderly has been presented at many international meetings including the International Meeting for Advanced Spinal Techniques.

Dr. Joseph and his family are active members of the Tampa Bay community. They have taken a special interest in the Make a Wish Foundation, and its goal of granting wishes and making life better for kids with life-threatening medical conditions. He also lends his time to the mission trips abroad which brings deformity focused spine surgeons and comprehensive teams to developing countries to teach local spine surgeons through didactics, work-shops, and surgery on local patients.

Share article on social media or email:

Biomedical Research Laboratories Named to Inc. 5000 List of America’s Fastest-Growing Companies for the 6th Time


Biomedical Research Laboratories (BRL) (brlscience.com) announced today that it has been included on the prestigious 2020 Inc. 5000 list of America’s fastest-growing companies for a 6th time. Published annually, the Inc. 5000 is an exclusive list of the nation’s fastest-growing private companies. Out of nearly seven million private companies moving the economy forward every day, Inc. 5000 reports that BRL ranks at 4,013 with an impressive growth rate of 87.18%. Companies such as Intuit, Zappos, Under Armour, Microsoft, Jamba Juice, Timberland, Clif Bar, Pandora, Patagonia, Oracle, are part of the notable alumni.

Started in 2008 by a team of bioengineers from UCSD, BRL is a global nutrition company founded on a commitment to improved health and wellness. What began as a human sports nutrition company evolved into a health and wellness product powerhouse. BRL has expanded their product offerings to include natural remedies, Hemp-based CBD products, weight loss and vitamin supplements. Since its inception, BRL has developed healthy solutions to improve energy, stamina and athletic performance using 100% drug-free, safe and legal ingredients. Each product offers the same levels of active ingredients used in human clinical studies for maximum benefit and wellness support. BRL products are manufactured in FDA-registered facilities and made from the highest quality ingredients.

“It’s an honor to be on this list among so many outstanding companies, and a true privilege to be included for a 6th time!” said Chris Jacob, Biomedical Research Laboratories’ CEO. “The market speaks for itself—there’s a tremendous demand for premium health supplements to help support everyday wellness. And we’re proud to offer our customers the best in nutritional supplements to make a difference in their daily lives and in their long-term health. It’s why we push ourselves everyday to continue innovating and discovering the most effective and beneficial ingredients and formulas. But we couldn’t do it without the excellence, passion, and hard work of our incredible BRL team.”

The BRL team’s vigorous commitment to supporting health and wellness for the community is palpable, especially in light of the current health situation. BRL leadership understands that more than ever consumers are looking for natural products to help navigate life and maintain health and wellness. Thus, all BRL operations have taken extensive sanitary precautions to ensure team, product and consumer safety. Our current mission is to continue creating innovative natural products that improve consumers’ well-being, and delivering them to their front door in the safest manner possible.

BRL’s top-selling nutritional supplements include INVIGOR8® Superfood Shake, EPO-BOOST® and TRIFUEL® (invigor8.com and brlsports.com). BRL’s keystone CBD products are Zebra CBD Rub, Zebra CBD Oils, and Zebra CBD Peppermint Mints. The company’s natural remedy products include Altitude-Rx®, Calm Legs® and Flexify™ provide lasting relief from serious medical conditions without the risk of harmful side effects (nativeorigins.com). BRL’s horse top supplements, EPO-EQUINE® and BleederShield®, are used by top horse owners and trainers around the world (brlequine.com). A growing pipeline of new products promises even greater growth for this company.

PRESS CONTACT:     Melissa Ramirez, 800-780-4331, melissa@brlscience.com

About Biomedical Research Laboratories

Founded by a team of bioengineers in 2008, Biomedical Research Laboratories creates innovative science-based sports nutrition and natural remedy products. Our sports nutrition products improve the performance of elite athletes and fitness enthusiasts alike. Our natural remedy products provide lasting relief from medical conditions without the risk of side effects. The company also produces nutrition products for racehorses and equine athletes.

The company is committed to improving the lives of its customers through science and nutrition. For the convenience of our customers, we offer our products directly from our websites. Our products are also sold in stores and by online retailers throughout the world. Please visit brlscience.com for more information.

Share article on social media or email:

Metrics Champion Consortium Announces — The 2020 Clinical Trial Risk and Performance Management vSummit, Sept. 8-10, 2020


MCC Logo

MCC Logo

The 2020 Clinical Trial Risk and Performance Management vSummit

A Metrics Champion Consortium Digital Conference

Tuesday-Thursday, Sept. 8-10, 2020

https://www.centerwatch.com/mcc-summit-2020

We’ve gone digital for next month’s MCC’s vSummit on Clinical Trial Risk and Performance Management — but not being in the same room won’t keep us from having deep, important conversations together on risk management and metrics.

We’ll be featuring sessions on topics like remote monitoring, vendor relationships, and survey creation. With these exclusive sessions, once can begin to develop new clinical trial skills and tools.

Here are some of the subjects one can get well on the way to mastering, all while enjoying one’s favorite evening drink in the living room:

  • Identifying root issues is key in determining appropriate corrective actions. This WCG MCC session will tackle the best ways to connect issue and risk management concepts to develop broad, effective solutions.
  • Bristol-Myers Squibb knows that the industry’s adjustment to risk-based monitoring also means the way we measure data needs to change. Discover what they’re doing to ensure their metrics monitoring system is effective and efficient.
  • To respond to the needs of COVID-19, Medtronic has developed and implemented a remote monitoring quality assessment tool. Learn about how it works and whether one’s team could benefit from some monitoring adjustments.
  • Clinical Pathways is sharing how risk-based monitoring should impact all clinical trial activities and the ways staff training can help sites move in this direction. Discover how risk-based monitoring coaching can shift a team toward success.
  • Selecting the right IT vendors requires a strong foundation in contract selection, best practices and benefit evaluation. Pharma Initiatives is sharing how to make these evaluations and set a team up for an effective system.
  • While ICH doesn’t define reliability, WCG Analgesic Solutions has worked on ways sponsors can define accuracy and reliability in their own risk-based monitoring procedures. Dig into these guidelines and find ways to meet regulatory requirements while improving a study’s success.
  • Corbus Pharmaceuticals is looking at examples of strong and weak vender relationships, sharing how teams can measure the productivity of these partnerships and what tools exist to support them.
  • Surveys are easy to send out but difficult to do well. MCC Ambassador Keith Dorricott knows how to solicit the most needed information and analyze the data in a way that helps improve vender and sponsor relationships. During these sessions and throughout the summit, one can learn from and interact with a great panel of industry experts from both large and small organization as well as attend the keynote from the FDA.

Sign up for the virtual summit now.

Conference Details

The 2020 Clinical Trial Risk and Performance Management vSummit

A Metrics Champion Consortium Digital Conference

Tuesday-Thursday, Sept. 8-10, 2020

https://www.centerwatch.com/mcc-summit-2020

Tuition:

MCC Member Pricing: $695

MCC Non-Member Pricing: $895

Significant team and MCC membership discounts are available.

Easy Ways to Register

Online: https://www.centerwatch.com/mcc-summit-2020

By phone: 888.838.5578 or 703.538.7600

About MCC

Leading the drug-development enterprise in the adoption and utilization of standardized metrics and benchmarks to drive performance improvement. Founded in 2006, MCC is the leading industry association dedicated to the development of standardized performance metrics to improve clinical trials. MCC provides the collaborative environment for biopharmaceutical and device sponsors, service providers and sites to improve clinical-trial development through use of MCC standardized performance metrics.

Share article on social media or email:

Dilated Blood Vessels in the Lung May Explain Low Oxygen Levels in Severe Cases of COVID-19


A new pilot study from the Icahn School of Medicine at Mount Sinai suggests that COVID-19 is causing significant dilation of the blood vessels of the lung, specifically the capillaries. This vasodilation is contributing to the very low oxygen levels seen in COVID-19 respiratory failure and also helps explain why the disease behaves differently than classic acute respiratory distress syndrome (ARDS). The study was published in the American Journal of Respiratory and Critical Care Medicine.

In classical ARDS, pulmonary inflammation leads to leaky pulmonary blood vessels that flood the lungs with fluid, making the lungs stiff and impairing oxygenation. Many patients with COVID-19 pneumonia demonstrate severe hypoxemia that is markedly out of proportion to the degree of lung stiffness. This disconnect between gas exchange and lung mechanics in COVID-19 pneumonia has raised the question of whether the mechanisms of hypoxemia in COVID-19 differ from those in classical ARDS.

The discovery was serendipitous. Researchers were initially assessing cerebral blood flow in mechanically ventilated COVID-19 patients with altered mental status to look for, among other things, abnormalities consistent with stroke. They used a robotic transcranial Doppler (TCD), the Lucid Robotic System by NovaSignal, to perform a “bubble study,” which is a non-invasive and painless ultrasound technique.

“It is remarkable that a diagnostic machine used to study the brain could give us insight into the pathophysiology of a pulmonary disease. The benefit of using this particular system was that automated monitoring allowed providers to assess cerebral blood flow while minimizing the potential for exposure to COVID-19,” said Alexandra Reynolds, MD, Assistant Professor of Neurosurgery, and Neurology, at the Icahn School of Medicine at Mount Sinai and Director of TeleNeurocritical Care for the Mount Sinai Health System.

During this study, agitated saline—saline with tiny microbubbles—is injected into the patient’s vein and TCD is used to determine if those microbubbles appear in the blood vessels of the brain. Under normal circumstances, these microbubbles would travel to the right side of the heart, enter the blood vessels of the lungs, and ultimately get filtered by the pulmonary capillaries, because the diameter of the microbubbles is bigger than the diameter of the pulmonary capillaries. If the microbubbles are detected in the blood vessels of the brain, it implies that either there is a hole in the heart, so that blood can travel from the right to the left side of the heart without going through the lungs, or that the capillaries in the lungs are abnormally dilated, allowing the microbubbles to pass through.

In the pilot study, 18 mechanically ventilated patients with severe COVID-19 pneumonia underwent TCD with bubble study. Fifteen out of the 18 (83 percent) patients had detectable microbubbles, indicating the presence of abnormally dilated pulmonary blood vessels. The number of microbubbles detected by the TCD correlated with the severity of hypoxemia, indicating that the pulmonary vasodilations may explain the disproportionate hypoxemia seen in many patients with COVID-19 pneumonia. Previous studies have demonstrated that only 26 percent of patients with classical ARDS have microbubbles during a bubble study; furthermore, the number of these microbubbles does not correlate with the severity of hypoxemia, implying that pulmonary vascular dilations are not a major mechanism of hypoxemia in classical ARDS.

“It is becoming more evident that the virus wreaks havoc on the pulmonary vasculature in a variety of ways. This study helps explain the strange phenomenon seen in some COVID-19 patients known as ‘happy hypoxia,’ where oxygen levels are very low, but the patients do not appear to be in respiratory distress. If these findings are confirmed in larger studies, pulmonary microbubble transit may potentially serve as a marker of disease severity or even a surrogate endpoint in therapeutic trials for COVID-19 pneumonia. Future studies that investigate the use of pulmonary vascular constrictors in this patient population may be warranted,” says senior author Hooman Poor, MD, Assistant Professor of Medicine (Pulmonary, Critical Care and Sleep Medicine) at the Icahn School of Medicine at Mount Sinai and Director of Pulmonary Vascular Disease at the Mount Sinai – National Jewish Health Respiratory Institute.

The pilot study has since expanded to collect data from approximately 80 patients, including those with less severe disease, and will evaluate the severity of microbubble transit and how it varies during the course of the disease.

About the Mount Sinai Health System

The Mount Sinai Health System is New York City’s largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report’s “Honor Roll” of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty by U.S. News & World Report.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

Share article on social media or email:

Avalon Healthcare Solutions Announces New Laboratory Benefit Management Agreement with Blue Cross and Blue Shield of Kansas City


News Image

Avalon represents an extremely effective and comprehensive approach for managing the complex and growing laboratory market.

Avalon is pleased to announce we have launched Avalon’s Genetic and Routine Testing Management solutions for Blue Cross and Blue Shield of Kansas City (Blue KC). Avalon is the leader in laboratory science and their programs support providers in performing appropriate diagnostic testing in the laboratory setting. Avalon and Blue KC are focused on provider education to ensure access to high-quality, cost-effective laboratory services to Blue KC’s members.

“We are pleased to bring our proven Laboratory Benefit Management platform to the Missouri market through this partnership,” said Dr. Bill Kerr, Chief Executive Officer at Avalon. “Blue KC’s focus on improving member access to appropriate genetic and routine testing will improve outcomes and while delivering savings to its members is perfectly aligned with Avalon’s mission.”

Dr. Greg Sweat, Chief Medical Officer at Blue KC, said “Avalon represents an extremely effective and comprehensive approach for managing the complex and growing laboratory market. The ability to provide members with access to appropriate testing while addressing the cost challenge was a critical factor in our selection of Avalon as our laboratory services management partner moving forward.”

Under the agreement, Blue KC members will gain access to an expanded laboratory coverage. Additionally, members and providers will benefit enhanced laboratory education, improved clinical care and cost savings from Avalon’s administration of evidence-based laboratory policies.

About Avalon Healthcare Solutions

Avalon is a healthcare information technology and specialty benefit management company focused on laboratory testing. Avalon provides a comprehensive program to facilitate management of all outpatient laboratory services across all providers, including independent, physician office, and hospital-based laboratories. Using an independent Clinical Advisory Board, Avalon has developed a suite of science-based laboratory policies addressing all testing categories. The majority of these policies, reflecting high-volume, low-cost services, are administered through proprietary, automated technology, typically saving health plans 7 to 12 percent on outpatient laboratory spend. For more information about Avalon, please visit http://www.avalonhcs.com.

About Blue Cross and Blue Shield of Kansas City Blue Cross and Blue Shield of Kansas City, the largest not-for-profit health insurer in Missouri and the only not-for-profit commercial health insurer in Kansas City, has been part of the Kansas City community since 1938. Blue Cross and Blue Shield of Kansas City provides health coverage services to more than one million residents in the greater Kansas City area, including Johnson and Wyandotte counties in Kansas and 30 counties in Northwest Missouri. Our mission: to provide affordable access to healthcare and to improve the health of our members. Blue Cross and Blue Shield of Kansas City is an independent licensee of the Blue Cross and Blue Shield Association. For more information on the company, visit its website at BlueKC.com.

Share article on social media or email:

New Survey from Power to Decide Shows Significant Support for Telehealth


“People recognize telehealth as a powerful and effective option to access the resources, information and medical care they need without having to overcome barriers associated with being under quarantine during COVID-19,” said Gillian Sealy, CEO, Power to Decide.

A new national survey released today by Power to Decide shows that a vast majority of respondents (77%) agree that telehealth is a useful method to get birth control when in-person visits with a provider are not possible. Yet, despite overwhelming support for telehealth, critical information gaps remain, specifically, only 36% of individuals reported being able to explain what telehealth is—with only 24% knowing how to find a telehealth provider. The results reflect responses from an online panel survey conducted in May 2020 of 500 women ages 18-29 in the United States.

“People recognize telehealth as a powerful and effective option to access the resources, information and medical care they need without having to overcome barriers associated with being under quarantine during COVID-19,” said Gillian Sealy, CEO, Power to Decide. “Access to telehealth services can be an important resource for women on limited incomes where transportation issues and taking time off from work are often cost prohibited when trying to access health care. In order to make the most of telehealth’s benefits, we must educate everyone regarding its availability and how to access such services.”

The nationally representative survey also showed 67% of respondents agree telehealth is an acceptable way to receive birth control. In addition, 57% of respondents reported they were likely to talk to their health care provider about telehealth options available to them in the next 6 months. However, only 25% understood they could use telehealth even without insurance.

“While telehealth can help bridge the access issues for many, it is not the answer for all, as some do not have the resources necessary to benefit from telehealth, such as reliable internet access,” continued Sealy. “For those individuals, we must continue to expand availability in all forms. Such action will help ensure all women have the power to decide if, when and under what circumstances to get pregnant and have a child.”

For more details, and information, about the Power to Decide telehealth survey, go here.

About the Survey: Data presented here are drawn from a survey conducted by Ask Your Target Market (AYTM), an online market research firm. Using AYTM’s panel, we surveyed 500 U.S. women between the ages of 18-29 in May 2020.

Power to Decide is a private, non-partisan, non-profit organization that works to ensure all people—no matter who they are, where they live or what their economic status might be—have the power to decide if, when and under what circumstances to get pregnant and have a child. Please visit us at http://www.PowerToDecide.org or follow us on Facebook and Twitter.

Share article on social media or email:

Voice Automated, Elite Dragon Medical Solution Provider Celebrates 25 years


“After 2 ½ decades, our tagline, “Your Voice Has Never Been More Powerful” has never been truer”, said Henry Majoue, Voice Automated Founder and COO

Voice Automated, an Elite Dragon Medical Solution provider, today announced the company’s 25 years of excellent customer service in delivering medical speech recognition solutions throughout North America.

“After 2 ½ decades, our tagline, ‘Your Voice Has Never Been More Powerful’ has never been truer,” said Henry Majoue, Voice Automated Founder and COO. “We are thrilled that over 25 years, Speech Recognition has become one of the most powerful tools available for Physicians and Healthcare Workers to complete narrative patient notes in Electronic Health Record Software.”

Voice Automated solutions not only save healthcare workers time and money but provide a better quality of life for our essential healthcare workforce.

While Voice Automated has continuously and reliably provided excellent customer service and solutions to the healthcare industry through its proprietary customer service delivery system, it has broadened its scope to also service, professional, legal, and law enforcement markets.

Looking to the future, CEO Trey Weiss said, “Fast, secure, and intelligent cloud-based speech recognition workflows and documentation are now the norm. To that end, we continue to make investments in speech recognition technologies that deliver the solutions our customers want; not only on PC but macOS, iOS, Android, and Chrome OS.”

Voice Automated operates from its headquarters in Irvine, CA, with sales and customer service offices in California and a new office in Toronto Canada. The company is an Elite provider of Dragon Medical One from Nuance as well as Dragon Medical Practice Edition, Dragon Professional Anywhere, Dragon Legal Anywhere, and Dragon Law Anywhere as well as SpeechLive from Philips.

To learn more about Voice Automated, please visit VoiceAutomated.com.

Visit us on Facebook | LinkedIn |Twitter

Share article on social media or email:



Inc. Magazine Unveils Its Annual List of America’s Fastest-Growing Private Companies—the Inc. 5000


News Image

Embark Safety Logo

“We are so proud and excited to have made the list with our fellow honorees! It is a testament to our amazing team and clients who are committed to creating a culture of safe drivers and communities,” said Embark Safety President, Edwin Sosa.

Last week, Inc. magazine revealed that Embark Safety is No. 1792 on its annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. The list represents a unique look at the most successful companies within the American economy’s most dynamic segment—its independent small businesses. Intuit, Zappos, Under Armour, Microsoft, Patagonia, and many other well-known names gained their first national exposure as honorees on the Inc. 5000.

Not only have the companies on the 2020 Inc. 5000 been very competitive within their markets, but the list as a whole shows staggering growth compared with prior lists as well. The 2020 Inc. 5000 achieved an incredible three-year average growth of over 500 percent, and a median rate of 165 percent. The Inc. 5000’s aggregate revenue was $209 billion in 2019, accounting for over 1 million jobs over the past three years.

Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found at http://www.inc.com/inc5000. The top 500 companies are also being featured in the September issue of Inc., available on newsstands August 18.

About Embark Safety

Embark Safety’s innovative system monitors employees’ driving records continuously and sends real-time notifications when new changes occur, such as violations, suspensions, and accidents. System allows companies to reduce accident risk, avoid litigation, and improve public safety. Headquartered in Orlando, Fl, we are a proud SaaS provider to more than 1,000 companies across the country and Canada.

CONTACT:     

Margaret Truitt, Communications Manager

Margaret.Truitt@embarksafety.com

407-536-7233

More about Inc. and the Inc. 5000

Methodology

The 2020 Inc. 5000 is ranked according to percentage revenue growth when comparing 2016 and 2019. To qualify, companies must have been founded and generating revenue by March 31, 2016. They had to be U.S.-based, privately held, for profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2019. (Since then, a number of companies on the list have gone public or been acquired.) The minimum revenue required for 2016 is $100,000; the minimum for 2019 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. Companies on the Inc. 500 are featured in Inc.’s September issue. They represent the top tier of the Inc. 5000, which can be found at http://www.inc.com/inc5000.

About Inc. Media

The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers, and the credibility that helps them drive sales and recruit talent. The associated Inc. 5000 Conference is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit http://www.inc.com.

For more information on the Inc. 5000 Conference, visit http://conference.inc.com/.

“The companies on this year’s Inc. 5000 come from nearly every realm of business,” says Inc. editor-in-chief Scott Omelianuk. “From health and software to media and hospitality, the 2020 list proves that no matter the sector, incredible growth is based on the foundations of tenacity and opportunism.”

The annual Inc. 5000 event honoring the companies on the list will be held virtually from October 23 to 27, 2020. As always, speakers will include some of the greatest innovators and business leaders of our generation.

Share article on social media or email:

Dr. Katinka Featured in Best Selling Book on Miracles in Medical Industry


Wakeup: Miracles of Healing From Around the World book - Dr. Katina van der Merwe

“I enjoyed writing my part of this book almost as much as I enjoyed reading the perspectives of other doctors,” Dr. Katinka explained.

Dr. Katina van der Merwe is included in the list of more than forty influential medical professionals who have contributed to the best-selling Amazon book, Wakeup: Miracles of Healing From Around the World, available now in Kindle format and in paperback.

Raised by her father, a chiropractic doctor in Johannesburg, South Africa, Dr. Katinka van der Merwe has the love for caring about others in her blood. As a young woman, she followed in her father’s footsteps and became a chiropractor herself.

Dr. Katinka completed extensive post graduate training in functional neurology and biologic medicine. She is the author of two books, “Taming the Beast: A Guide to Conquering Fibromyalgia” and “Putting Out the Fire: New Hope for RSD/CRPS.”

The book focuses on the miracles that this collection of doctors have seen in the medical world. It serves a workbook of sorts to help expose patients and other medical professionals to these miracles, both small and large. The goal is to bring hope to those currently living through medical emergencies and issues, proving that miracles are possible, no matter how slim the odds may seem.

“I enjoyed writing my part of this book almost as much as I enjoyed reading the perspectives of other doctors,” Dr. Katinka explained. “It is always interesting to see the world through someone else’s eyes. I was able to learn things and look at situations with a fresh perspective, and what I learned will absolutely stick with me as I continue to help my patients for years to come.”

The stories span from all over the world, covering tragedies and heartbreaks, love stories, silver lining moments, obstacles, and amazing words of inspiration. Within the book, each author shares their example of a miracle that changed their lives and stayed with them throughout their careers. Additionally, this book tells a bit about their illustrious careers and how they have changed the lives of thousands of patients around them.

The book currently has a 5-star rating on Amazon and has received glowing reviews from patients, holistic doctors, and more. “To see a book that really inspires everyone in the medical field is quite something,” Dr. Katinka says. “Sometimes, medical professionals can be a bit competitive, but this book shows how much we can accomplish if we listen and learn from one another.”

Also included in this collaborative book are Dr. Joe Dispenza, Dr. Paul Drouin, Dr. John W. Brimhall, Dr. Patrick K. Porter, Mariel Hemingway, and many more influential medical professionals.

For more information about Dr. Katinka van der Merwe and her 12 Week Neurologic Rehabilitation program, please visit The Spero Clinic website.

More About The Spero Clinic

At The Spero Clinic, Dr. Katinka van der Merwe and her team use a Neurologic Recovery Program to help patients who are suffering from severe chronic pain like RSD/CRPS. They focus on Neurologic Rehabilitation and restoring balance to the Autonomic Nervous System. Dr. Katinka’s world leading 12 Week Neurologic Rehabilitation program helps treat hopeless cases worldwide.

For more information, please visit https://thesperoclinic.com/ or call us at (479) 304-8202.

Share article on social media or email: